James Tsai

Hematology | Oncology
201 Laursen St
Hemet, CA 92543

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Perianal basosquamous carcinoma treated with radiation therapy, a case report.

Perianal basosquamous carcinoma treated with radiation therapy, a case report.

Journal: Journal of gastrointestinal oncology
Published: December 07, 2022

Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.

Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.

Journal: JAMA oncology
Published: July 08, 2021

Concomitant KRAS and BRAF mutations in colorectal cancer.

Concomitant KRAS and BRAF mutations in colorectal cancer.

Journal: Journal of gastrointestinal oncology
Published: June 12, 2019

The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma.

The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma.

Journal: JCI insight
Published: February 08, 2018

Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells.

Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells.

Journal: Biomarker research
Published: November 18, 2014

RAF inhibitors that evade paradoxical MAPK pathway activation.

RAF inhibitors that evade paradoxical MAPK pathway activation.

Journal: Nature
Published: January 24, 2014

Vemurafenib: the first drug approved for BRAF-mutant cancer.

Vemurafenib: the first drug approved for BRAF-mutant cancer.

Journal: Nature reviews. Drug discovery
Published: October 13, 2012
Showing 1-7 of 7

Last Updated: 09/26/2026